The Iron Deficiency Anemia Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the iron deficiency anemia treatment has seen significant growth in recent years. The market which was $7.85 billion in 2024 is projected to expand to $8.89 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.4%.
The global market for iron deficiency anemia treatment is projected to reach $14.54 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%.
Download Your Free Sample of the 2025 Iron Deficiency Anemia Treatment Market Report and Uncover Key Trends Now!The key drivers in the iron deficiency anemia treatment market are:
• Increase in research and development investments
• Rising risk of anemia in pregnancy
• Growing nutritional deficits among the population
• Increasing healthcare awareness and prevalence of iron deficiency anemia
The iron deficiency anemia treatment market covered in this report is segmented –
1) By Treatment Type: Medications, Blood Transfusions, Other Treatment Types
2) By Drug Type: Ferrous Sulfate, Iron Carbohydrates, Other Drug Types
3) By Therapy Areas: Inflammatory Bowel Disease, Oncology, Other Therapy Areas
4) By Route Of Administration: Oral, Injectable
5) By End User: Hospitals, Clinics, Home Care Settings, Pharmacies
The key trends in the iron deficiency anemia treatment market are:
• Wearable hemoglobin monitors are an emerging trend in the market.
• The use of patient chatbots is becoming increasingly popular.
• The development and use of iron absorption enhancers is a notable trend.
• Remote monitoring platforms and neurocognitive monitoring are shaping the future of the market.
Major players in the iron deficiency anemia treatment market are:
• Sanofi SA
• Fresenius SE & Co. KGaA
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Sandoz Group AG
• Daiichi Sankyo Company Limited
• Lupin Limited
• Zydus Lifesciences Limited
• Alkem Laboratories
• Pharmascience Inc.
• American Regent Inc.
• PharmaNutra S.p.A.
• Rockwell Medical Inc.
• Keryx Biopharmaceuticals Inc.
• Akebia Therapeutics Inc.
• Pharmacosmos A/S
• Pieris Pharmaceuticals Inc.
• AdvaCare Pharma USA LLC
• Apotex Inc.
• Shield Therapeutics plc
North America was the largest region in the iron deficiency anemia treatment market in 2024